Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain.


Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, Pennsylvania, 19096; Chief Medical Officer, CytoDyn Inc, 111 Main St, Suite 660, Vancouver, WA, 98660, USA. Electronic address: [Email]


The figure describes the location of UHRF1 (Ubiquitin-like with containing PHD and RING Finger domains 1) gene, mRNA and protein synthesis in the tumor cell and its structural domains with a focus on the docking of Naphthazarin on the SRA domain of UHRF1, resulting in reduction of tumor size.


Cancer,SRA domain,UHRF1,Universal oncogene,

OUR Recent Articles